Aarti Pharmalabs Limited, a active public limited company, was established on 22 November 2019 in Vapi, Gujarat, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: L24100GJ2019PLC110964. Registered under ROC Roc Ahmedabad. it is listed on BSE: 543748. It has an authorized capital of ₹50.00 Cr and a paid-up capital of ₹45.32 Cr.
Formerly known as Aarti Organics Limited. It upholds a compliant status. In 2024, it reported revenue of ₹1,513.14 Cr and a net worth of ₹1,621.46 Cr. Employing 2,004 professional, Its leadership includes Vinay Gopal Nayak (Director), Nehal Garewal (Director), Hetal Gogri Gala (Managing Director). Past directors included Vinay Gopal Nayak, Nehal Garewal, Hetal Gogri Gala. It holds ₹400.00 Cr open charges and ₹75.00 Cr settled loans. Its latest AGM occurred on 22 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. 22/C/1 & 22/C/2, 1St Phase, G.I.D.C. Vapi,, Vapi, Gujarat, 396195.
L24100GJ2019PLC110964
110964
22 November 2019
₹50.00 Cr
₹45.32 Cr
Roc Ahmedabad
Listed (BSE: 543748)
Active
Explore comprehensive insights into Aarti Pharmalabs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vinay Gopal Nayak | Director | 17 Oct 2022 | Current |
| Nehal Garewal | Director | 13 May 2024 | Current |
| Hetal Gogri Gala | Managing Director | 07 Aug 2021 | Current |
| Rashesh Chandrakant Gogri | Director | 07 Aug 2021 | Current |
| Bhavesh Rasiklal Vora | Director | 17 Oct 2022 | Current |
| Jeenal Kenil Savla | Director | 17 Oct 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 23 Feb 2023 | Past |
| Pramod Abcsdd | Additional Director | 06 Aug 2024 | Past |
| Pramod Abcsdd | Director | 17 Oct 2022 | Past |
| Pramod Abcsdd | Additional Director | 27 Sep 2021 | Past |
| Pramod Abcsdd | Director | 17 Oct 2022 | Past |
| Pramod Abcsdd | Additional Director | 23 Feb 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aarti Pharmalabs Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 0.04% increase. The company also saw a substantial improvement in profitability, with a 16.84% increase in profit. The company's net worth Soared by an impressive increase of 12.71%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Aarti Pharmalabs had a promoter holding of 8.61% and a public holding of 91.40%. The company had 1 Subsidiary and 1 Joint Venture. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹4,000,000,000.00
₹750,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Mar 2025 | Idbi Bank Limited | ₹75.00 Cr | Open |
| 08 Sep 2024 | Citi Bank N.A. | ₹70.00 Cr | Open |
| 08 Sep 2024 | Citi Bank N.A. | ₹30.00 Cr | Open |
| 09 Feb 2023 | Axis Bank Limited | ₹75.00 Cr | Open |
| 11 Jan 2023 | Standard Chartered Bank | ₹75.00 Cr | Open |
Explore comprehensive loan charge details -
Aarti Pharmalabs has a workforce of 2004 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Aarti Pharmalabs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aarti Pharmalabs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 28 Mar 2023 via Charge ID 100699468 with Sbicap Trustee Company Limited was fully satisfied on 09 Oct 2025. was documented.
The activity Aarti Pharmalabs Limited last Annual general meeting of members was held on 22 Sep 2025 as per latest MCA records. was completed.
Aarti Pharmalabs Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.
Progress on A charge with Idbi Bank Limited amounted to Rs. 75.00 Cr with Charge ID 101072057 was registered on 17 Mar 2025. was documented.
The activity Jeevan Bhargav Mondkar was appointed as a Company Secretary was appointed as a Company Secretary on 19 Dec 2024 & has been associated with this company since 11 months 6 days . was completed.
The activity A charge with Citi Bank N.A. amounted to Rs. 70.00 Cr with Charge ID 100995906 was registered on 08 Sep 2024. was completed.
When Aarti Industries released their Q3 FY24 results, the topline went up by 3.84% but profit went down by 9.49% YoY. Compared to last quarter, revenue grew by 19.12% and profit increased by 36.26%. Expenses also increased. Operating income went up by 16.43% but decreased by 21.26% YoY. EPS is ₹3.42, down by 9.28% YoY. Stock returns are not great. Analysts have mixed opinions, but overall, just hold on and keep an eye on future results..
Pharma segment will continue to be one of the major participants in the growth, says Rajendra V Gogri..
The CIN of Aarti Pharmalabs Limited is L24100GJ2019PLC110964.
Aarti Pharmalabs Limited is headquartered at Plot No. 22/C/1 & 22/C/2, 1St Phase, G.I.D.C. Vapi,, Vapi, Gujarat, 396195.
Aarti Pharmalabs Limited was incorporated on 22 November 2019.
The current directors of Aarti Pharmalabs Limited are
The primary industry of Aarti Pharmalabs Limited is Manufacturing.
Aarti Pharmalabs Limited is listed. It is listed on BSE: 543748.
The authorized capital of Aarti Pharmalabs Limited is ₹50.00 Cr, and the paid-up capital is ₹45.32 Cr.
The compliance status of Aarti Pharmalabs Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX